Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?
Angiogenesis is essential for the growth and metastasis of solid tumors. The tumor endothelium exists in a state of chronic activation and proliferation, fueled by the tumor milieu where angiogenic mediators are aberrantly over-expressed. Uncontrolled tumor growth, immune evasion, and therapeutic re...
Main Authors: | Wagner, Samuel C., Ichim, Thomas E., Ma, Hong, Szymanski, Julia, Perez, Jesus A., Lopez, Javier, Bogin, Vladimir, Patel, Amit N., Marincola, Francisco M., Kesari, Santosh |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625691/ |
Similar Items
-
Safety of targeting tumor endothelial cell antigens
by: Wagner, Samuel C., et al.
Published: (2016) -
Xenon in the treatment of panic disorder: an open label study
by: Alexander Dobrovolsky, et al.
Published: (2017-06-01) -
Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™
by: Ichim, Thomas E, et al.
Published: (2015) -
Pancreatic Islet Vasculature Adapts to Insulin Resistance Through Dilation and Not Angiogenesis
by: Dai, Chunhua, et al.
Published: (2013) -
Overcoming tumor immune evasion with an unique arbovirus
by: Lyday, Bruce, et al.
Published: (2015)